LLY Lilly (Eli)

$1099.30 -1.17%

Healthcare · Pharmaceutical Preparations

Lilly (Eli) (LLY) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.04 trillion. Shares last traded at $1099.30, 7.0% below their 52-week high. Over the past year the stock is up 39.0%. LLY trades at a price-to-earnings ratio of 50.16, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 31.7%, above the peer median of -0.1%. Revenue grew 44.7% year over year. The shares yield 1.1% in dividends.

Market Cap

$1.04T

Shares Out

941.7M

EPS (TTM)

$36.23

P/E Ratio

30.34

P/S Ratio

15.88

P/B Ratio

33.18

Dividend / Share

$11.60

Dividend Yield

1.06%

52-Week High

$1182.28

52-Week Low

$623.90

Volume

115,936

Avg Vol (3m)

130,421.778

Performance

-5.16%

+8.06%

+19.83%

+4.50%

YTD

+1.75%

+39.02%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

54.16

SMA (50)

$1011.14

SMA (200)

$965.79

Price vs SMA50

+8.72%

Price vs SMA200

+13.82%

ATR (14)

$35.31

Financials

Revenue

$65.2B

Net Income

$20.6B

Gross Margin

—

Operating Margin

—

Net Margin

31.7%

Return on Equity

66.2%

Return on Assets

17.7%

Current Ratio

1.50

Debt / Equity

1.26

Revenue Growth (YoY)

+44.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$8.26	2026-04-30
FY 2025	$22.95	2026-02-12
Q3 2025	$15.56	2025-10-30
Q2 2025	$9.35	2025-08-07
Q1 2026	$3.06	2026-04-30
FY 2025	$11.71	2026-02-12

Full earnings history →

Pharmaceutical Preparations peers

LLY vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

50.16 / 16.82 med

+198% premium

P/S vs peers

15.88 / 3.54 med

+349% premium

Net margin vs peers

31.7% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.